What are Rybelsus Tablets (Semaglutide)?
RYBELSUS tablets (semaglutide) are available in 3 mg, 7 mg, or 14 mg and are used along with diet and exercise to improve blood sugar in adults with type 2 diabetes. It acts in many ways
- Increase insulin secreted by the pancreas.
- Stimulate the pancreas to release adequate insulin when the sugar level is higher in the blood.
- It slows down metabolism, so that blood sugar does not spike immediately after meals.
- It prevents your liver from releasing too much sugar.
What is Rybelsus Tablets used for?
Rybelsus Tablets is not recommended primary choice of medicine for treating diabetes. Do not use Rybelsus Tablets to treat people with type 1 and adults above 18 years of age. Rybelsus dose for weight loss – Rybelsus Tablets might aid in some weight reduction even if though it’s not for weight loss. It does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death.
Take Rybelsus Tablets once daily, immediately after waking up on an empty stomach with water. Limit your water intake to no more than 4 ounces. You can eat or drink anything after 30 minutes of taking Rybelsus Tablets. Waiting for a shorter period will reduce the effectiveness of Rybelsus Tablets. Wait more than 30 minutes before you eat anything to increase the absorption of Rybelsus.
- Swallow the entire Rybelsus tablet without cutting, crushing, or chewing.
- Initially, Rybelsus 3mg tablets once daily for 30 days may be prescribed. After 30 days, the dosage may be increased to Rybelsus 7 mg once daily. After another 30 days, the dosage may be increased to Rybelsus 14 mg once daily if additional glycemic control is needed.
- Your doctor may switch prescriptions between Ozempic and Rybelsus.
Warnings and Precautions
What are Rybelsus side effects?
If using Rybelsus, you must inform your doctor if you find the following symptoms and issues:
- Pancreatitis – You must discontinue using Rybelsus promptly.
- Diabetic Retinopathy Complications Continue to monitor for diabetic retinopathy.
- Hypoglycaemia – Concomitant use of Ozempic or another form of the insulin secretagogue or insulin may increase the risk of hypoglycemia.
- Acute Kidney Injury – Monitor renal function.
- Hypersensitivity Reactions (e.g., anaphylaxis and angioedema) – Discontinue OZEMPIC.
- Acute Gallbladder Disease.
- Lactation – Breastfeeding is not recommended.
- Females and Males of Reproductive Potential – Discontinue Rybelsus at least two months prior if a female is planning pregnancy. This is due to the long washout period for semaglutide.
- You or any of your family ever had thyroid.
Symptoms of Hypoglycaemia may include:
- dizziness or light-headedness
- blurred vision
- anxiety, irritability, or mood changes
- slurred speech
- confusion or drowsiness
- fast heartbeat
- feeling jittery
While using Rybelsus Tablets, the most common adverse reactions are:
- abdominal pain
Other severe allergic reactions could include one or more of the following symptoms:
- Swelling of your face, lips, tongue, or throat.
- A problem in breathing or swallowing.
- Severe rash or itching.
- Fainting or feeling dizzy.
- Very rapid heartbeat.
Storage of Rybelsus Tablets
- Store Rybelsus Tablets at a dry and clean place where the temperature is maintained between 68°F to 77°F (20°C to 25°C)
- Under certain conditions, an excursion is permitted to 59°F to 86°F (15°C to 30°C).
- Store the Rybelsus Tablets in the original bottle.
- Protect the Rybelsus Tablets from moisture.
Remember that regular physical exercise is crucial to treating diabetes or managing prediabetes, along with your diet planning, weight management, and medications. Because your cells become more responsive to insulin while you are active, your blood glucose, also known as blood sugar, can be lowered more successfully. Take your medications regularly and follow up with your healthcare specialist.
30 Rybelsus Tablets (14mg) - Northern Insulin
RYBELSUS tablets (semaglutide) are available in 3, 7, or 14 mg and are used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.